Antibiotic sensitivity testing

The 50-Year Cover-Up Killing Millions

Antibiotic-resistant infections affect 2 million Americans annually, leading to the death of at least 23,000. Even more die from complications related to the infections, and the numbers are steadily growing.

According to the Infectious Disease Society of America (IDSA), just one organism — methicillin resistant Staphylococcus aureus, better known as MRSA — kills more Americans each year than the combined total of emphysema, HIV/AIDS, Parkinson's disease, and homicide.

A 2015 report commissioned by U.K. Prime Minister David Cameron estimates that by 2050, the annual global death toll from antibiotic-resistant disease will reach 10 million, and the global cost for treatment will be around $100 trillion.

May 31, 2016 | Source: Mercola | by Dr. Joseph Mercola

Antibiotic-resistant infections affect 2 million Americans annually, leading to the death of at least 23,000.1 Even more die from complications related to the infections, and the numbers are steadily growing.

According to the Infectious Disease Society of America (IDSA), just one organism — methicillin resistant Staphylococcus aureus, better known as MRSA — kills more Americans each year than the combined total of emphysema, HIV/AIDS, Parkinson’s disease, and homicide.2

A 2015 report3,4 commissioned by U.K. Prime Minister David Cameron estimates that by 2050, the annual global death toll from antibiotic-resistant disease will reach 10 million, and the global cost for treatment will be around $100 trillion.

Experts have been warning about the implications of antibiotic resistance for years, but as their warnings have largely been ignored, the number of strains developing resistance to even our strongest antibiotics has been allowed to grow unabated.

While overuse of antibiotics in medicine and widespread use of antibacterial household products (items containing triclosan5) are part of the problem, the inappropriate use of antibiotics in farming bears the heaviest responsibility for creating the antibiotic-resistant superbug crisis of today.

An estimated 80 percent of total antibiotic sales in the U.S. end up in livestock. For example, commercial chicken producers have a history of treating each egg with gentamicin, an antibiotic listed as “essential” to human medicine. One chicken producer has seen the light though, and has abandoned this risky practice.

Perdue Proves Meat Production Can Prosper Without Drugs

Perdue Farms no longer uses gentamicin. In fact, according to a recent report by Mother Jones,6 the only antibiotic remaining in use at Perdue is narasin, an antibiotic not used in human medicine, and only about one-third of its chickens ever get it. (It’s used to treat a parasitic intestinal condition called coccidiosis.)

Any other antibiotics are administered to sick birds only (about 4 percent of all birds). According to Mother Jones:

“Perdue … the country’s fourth-largest poultry producer, has set out to show that the meat can be profitably mass-produced without drugs.

In 2014, the company eliminated gentamicin from all its hatcheries, the latest stage of a quiet effort started back in 2002 to cut the routine use of antibiotics from nearly its entire production process.”

Interestingly, Perdue fared the best in a 2010 Consumer Reports test7 checking for the presence of the foodborne pathogens salmonella and campylobacter in commercial chicken meat. Fifty-six percent of Perdue’s chickens were free of both pathogens.

Its main competitors, Tyson and Foster Farms, both had 80 percent of their chickens tested positive for one or both bacteria. Organic store brand chickens had no salmonella at all, but 57 percent still harbored campylobacter.

According to Consumer Reports, “This is the first time since we began testing chicken that one major brand has fared significantly better than others across the board.” Even back then, Perdue’s exemplary success was attributed to its more stringent policies on antibiotics.